A Tumblr Takeover? ...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$49.51 0.88 | 1.81%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 49.51 |
| 52 Week High | 49.86 |
| 52 Week Low | 36.73 |
| Avg. Daily Vol. (Mil) | 0.77 |
| Beta (3 year) | 0.54 |
| Share Related Items | |
| Mkt Cap (Mil) | 3,228.37 |
| Shares Out (Mil) | 65.21 |
| Float (Mil) | 48.98 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.60 |
| Current Ratio | 5.20 |
| LT Debt/ Equity | 0.37 |
| Total Debt / Equity | 0.37 |
| Valuation Ratios | |
| Price Earnings | 28.60 |
| Price/Sales | 3.42 |
| Price/Book | 3.18 |
| Price/Cash Flow | 17.00 |
| Per Share Data | |
| Earnings | 1.73 |
| Sales | 14.49 |
| Book Value | 15.56 |
| Cash Flow | 2.91 |
| Business Summary | |
|---|---|
| Cubist Pharmaceuticals, Inc. is engaged in the research, development & commercialization of novel therapies to treat unmet medical needs in acute care environment. | |
| General Information | |
| 65 Hayden Avenue
Lexington, MA 02421 |
|
| www.cubist.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 762 | |
| CEO: Michael W. Bonney | |
| Short Interest | |
| Current Month (Mil) | 6.76 |
| Previous Month (Mil) | 6.86 |
| Short Interest Ratio (Days) | 8.50 |
| Management Effectiveness | |
| Return on Equity | 12.60 |
| Return on Assets | 6.70 |
| Return on Investments | 9.20 |
| Profitability | |
| Gross Margin | 82.00 |
| EBIT Margin | 19.40 |
| Profit Margin | 13.50 |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorGARP Growers for Summer 2013
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
Latest CBST Headlines from TheStreet
- Cubist Rises On Unusually High Volume (CBST) 04.02.13 | 04:04 pm
- 'Mad Money' Lightning Round: Solar Capital Is a Winner 03.08.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Follow the Market Leaders 03.07.13 | 08:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 01.22.13 | 02:01 pm
- FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugs 11.12.12 | 10:11 am
- Cubist Stock Hits New 52-Week High (CBST) 09.21.12 | 03:09 pm
- Cramer's 'Mad Money' Recap: When Progress Isn't Good 09.18.12 | 08:09 pm
- Cubist Stock Hits New 52-Week High (CBST) 09.13.12 | 02:09 pm
- Nektar Therapeutics Is a Short 09.12.12 | 07:09 am
- Cubist Reaches New 52-Week High (CBST) 09.04.12 | 01:09 pm
Press Releases for CBST
- Cubist Obtains Remaining Rights To Ceftolozane From Astellas - Business Wire 03.11.13 | 08:03 am
- Michael Tomsicek, Cubist CFO (Photo: Business Wire) - Business Wire 03.04.13 | 07:03 am
- FDA Grants QIDP And Fast Track Designations For Cubist’s Late-Stage Antibiotic Candidates - Business Wire 02.28.13 | 04:02 pm
- Cubist Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- Cubist Announces Exclusive Option To Acquire Adynxx - Business Wire 02.25.13 | 08:02 am
- Cubist To Present At February Investor Conferences - Business Wire 01.29.13 | 08:01 am
- Cubist Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 01.23.13 | 04:01 pm
- Thomas J. DesRosier (Photo: Business Wire) - Business Wire 01.08.13 | 08:01 am
- Cubist Announces Full-Year 2012 Revenues And Provides Business Update - Business Wire 01.07.13 | 07:01 am
- Heptares Partners With Cubist To Research New Medicines Targeting GPCRs - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for CBST
- Jump On Board With These 2 Companies - Seeking Alpha 04.22.13 | 09:04 am
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Stocks Tumble On Disappointing Earnings Reports - Investor's Business Daily 10.19.12 | 04:10 pm
- Stocks Hit Fresh Intraday Lows; Google Reverses Lower - Investor's Business Daily 10.19.12 | 03:10 pm
- Stocks Headed For Weaker Start; Polaris Motors Up - Investor's Business Daily 10.18.12 | 09:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- Stocks Mixed In Afternoon Trade; Homebuilders Lead - Investor's Business Daily 10.17.12 | 01:10 pm
